BAOBING ZHAO

Prof. BAOBING ZHAO

Shandong University
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Developmental Cell
Verified
Journal Article
Closed access
BZBAOBING ZHAO
BAOBING ZHAO
YMYang Mei
Yang Mei
MSMatthew J. Schipma
Matthew J. Schipma
EREric Wayne Roth
Eric Wayne Roth
RBReiner Bleher
Reiner Bleher
PJPeng Ji
Peng Ji

1 August 2022 in Leukemia
Verified
Journal Article
Open access
PDF file
PFPanpan Feng
Panpan Feng
DCDawei Chen
Dawei Chen
XWXia Wang
Xia Wang
YLYanxia Li
Yanxia Li
ZLZhenyu Li
Zhenyu Li
CJChunyan Ji
Chunyan Ji
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignant leukemia with extremely limited treatment for relapsed patients. N6‐methyladenosine (m6A) reader insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) participates in the initiation and growth of cancers by communicating with various targets. Here, we found IGF2BP2 was highly expressed in T-ALL. Gain and loss of IGF2BP2 demonstrated IGF2BP2 was essential for T-ALL cell proliferation in vitro and loss of IGF2BP2 prolonged animal survival in a human T-ALL xenograft model. Mechanistically, IGF2BP2 directly bound to T-ALL oncogene NOTCH1 via an m6A dependent manner. Furthermore, we identified a small-molecule IGF2BP2 inhibitor JX5 and treatment of T-ALL with JX5 showed similar functions as knockdown of IGF2BP2. These findings not only shed light on the role of IGF2BP2 in T-ALL, but also provide an alternative γ‑Secretase inhibitors (GSI) therapy to treat T-ALL.

16 November 2017 in Leukemia
Verified
Journal Article
Open access
PDF file
YMYang Mei
Yang Mei
BZBAOBING ZHAO
BAOBING ZHAO
ABA A Basiorka
A A Basiorka
JYJ Yang
J Yang
LCL Cao
L Cao
PJP Ji
P Ji
Anemia is characteristic of myelodysplastic syndromes (MDS). The mechanisms of anemia in MDS are unclear. Using a mouse genetic approach, here we show that dual deficiency of mDia1 and miR-146a, encoded on chromosome 5q and commonly deleted in MDS (del(5q) MDS), causes an age-related anemia and ineffective erythropoiesis mimicking human MDS. We demonstrate that the ageing bone marrow microenvironment is important for the development of ineffective erythropoiesis in these mice. Damage-associated molecular pattern molecules (DAMPs), whose levels increase in ageing bone marrow, induced TNFα and IL-6 upregulation in myeloid-derived suppressor cells (MDSCs) in mDia1/miR-146a double knockout mice. Mechanistically, we reveal that pathologic levels of TNFα and IL-6 inhibit erythroid colony formation and differentially affect terminal erythropoiesis through reactive oxygen species-induced caspase-3 activation and apoptosis. Treatment of the mDia1/miR-146a double knockout mice with all-trans retinoic acid, which promoted the differentiation of MDSCs and ameliorated the inflammatory bone marrow microenvironment, significantly rescued anemia and ineffective erythropoiesis. Our study underscores the dual roles of the ageing microenvironment and genetic abnormalities in the pathogenesis of ineffective erythropoiesis in del(5q) MDS.

1 October 2016 in Experimental Hematology
Verified
Journal Article
Closed access
BZBAOBING ZHAO
BAOBING ZHAO
YMYang Mei
Yang Mei
JYJing Yang
Jing Yang
PJPeng Ji
Peng Ji

25 September 2010 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
JWJifeng Wang
Jifeng Wang
BZBAOBING ZHAO
BAOBING ZHAO
WZWei Zhang
Wei Zhang
XWXuan Wu
Xuan Wu
RWRuoyu Wang
Ruoyu Wang
YSYuemao Shen
Yuemao Shen

5 November 2021 in Advanced Science
Verified
Journal Article
Open access
PDF file
ZLZhiyuan Lu
Zhiyuan Lu
LHLixia Huang
Lixia Huang
YLYanxia Li
Yanxia Li
YXYan Xu
Yan Xu
RZRuihao Zhang
Ruihao Zhang
BZBAOBING ZHAO
BAOBING ZHAO
Lipid metabolism is essential for stemness maintenance, self‐renewal, and differentiation of stem cells, however, the regulatory function of cholesterol metabolism in erythroid differentiation is poorly studied. In the present study, a critical role for cholesterol homeostasis in terminal erythropoiesis is uncovered. The master transcriptional factor GATA1 binds to Sterol‐regulatory element binding protein 2 (SREBP2) to downregulate cholesterol biosynthesis, leading to a gradual reduction in intracellular cholesterol levels. It is further shown that reduced cholesterol functions to block erythroid proliferation via the cholesterol/mTORC1/ribosome biogenesis axis, which coordinates cell cycle exit in the late stages of erythroid differentiation. The interaction of GATA1 and SREBP2 also provides a feedback loop for regulating globin expression through the transcriptional control of NFE2 by SREBP2. Importantly, it is shown that disrupting intracellular cholesterol hemostasis resulted in defect of terminal erythroid differentiation in vivo. These findings demonstrate that fine‐tuning of cholesterol homeostasis emerges as a key mechanism for regulating erythropoiesis.